Diagnos Laboratorium Utama Tbk. vs Pool Advista Finance Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Pool Advista Finance Tbk. trades at Rp56 (market cap 194.36B, 7.29M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Pool Advista Finance Tbk. is more actively traded (7.29M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | POLA | |
|---|---|---|
Market Cap | 319B | 194.36B |
Volume | 124.3K | 7.29M |
Lot | 1.24K | 72.87K |
Turnover | 28.28M | 411.46M |
Average Price | 227.48 | 56.46 |
Value | 28.28M | 411.46M |
Indicative Equilibrium Price | 228 | 56 |
Indicative Equilibrium Volume | 100 | 5.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pool Advista Finance Tbk (the Company), formerly PT Indojasa Pratama Finance was established based on Notarial Deed of Paulus Widodo Sugeng Haryono, S.H., No. 65 dated May 21, 2001. In 2002, Indojasa Finance obtained a business license as a Financing Company, and in 2003, Indojasa Finance entered the capital market by issuing bonds.
Read more on POLA →